Sự THAY ĐổI CấU TRúC KHÔNG GIAN ĐOạN TRONG MàNG CủA THụ QUAN HORMONE TăNG TRƯởNG TRONG QUá TRìNH HOạT HóA
Abstract
Tóm tắt
Article Details
Tài liệu tham khảo
Brown, R., Adams, J., Pelekanos, R., Wan, Y., McKinstry, W., Palethorpe, K., et al. (2005). Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nature structural & molecular biology, 12(9), 814-821.
Chen, C., Brinkworth, R., & Waters, M. J. (1997). The role of receptor dimerization domain residues in growth hormone signaling. Journal of Biological Chemistry, 272(8), 5133.
Cunningham, B., & Wells, J. (1991). Rational design of receptor-specific variants of human growth hormone. Proceedings of the National Academy of Sciences, 88(8), 3407.
Fuh, G., Cunningham, B. C., Fukunaga, R., Nagata, S., Goeddel, D. V., & Wells, J. A. (1992). Rational design of potent antagonists to the human growth hormone receptor. Science, 256(5064), 1677.
Gebert, C. A., S. H. Park, et al. (1997). "Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation." Molecular endocrinology 11(4): 400-414.
Gebert, C. A., S. H. Park, et al. (1999). "Termination of growth hormone pulse-induced STAT5b signaling." Molecular endocrinology 13(1): 38-56.
Gent, J., Van Kerkhof, P., Roza, M., Bu, G., & Strous, G. J. (2002). Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proceedings of the National Academy of Sciences of the United States of America, 99(15), 9858.
Gether, U., Lin, S., Ghanouni, P., Ballesteros, J. A., Weinstein, H., & Kobilka, B. K. (1997). Agonists induce conformational changes in transmembrane domains III and VI of the 2 adrenoceptor. The EMBO journal, 16(22), 6737-6747.
Harding, P. A., Wang, X., Okada, S., Chen, W. Y., Wan, W., & Kopchick, J. J. (1996). Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization. Journal of Biological Chemistry, 271(12), 6708.
Livnah, O., Johnson, D. L., Stura, E. A., Farrell, F. X., Barbone, F. P., You, Y., et al. (1998). An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nature structural & molecular biology, 5(11), 993-1004.
Ogawa, H., Qiu, Y., Ogata, C. M., & Misono, K. S. (2004). Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain. Journal of Biological Chemistry, 279(27), 28625.
Poger, D., & Mark, A. E. (2010). Turning the growth hormone receptor on: Evidence that hormone binding induces subunit rotation. Proteins: Structure, Function, and Bioinformatics, 78(5), 1163-1174.
Ross, R., Leung, K., Maamra, M., Bennett, W., Doyle, N., Waters, M., et al. (2001). Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer. Journal of Clinical Endocrinology & Metabolism, 86(4), 1716.
Rowlinson, S., Behncken, S., Rowland, J., Clarkson, R., Strasburger, C., Wu, Z., et al. (1998). Activation of chimeric and full-length growth hormone receptors by growth hormone receptor monoclonal antibodies. Journal of Biological Chemistry, 273(9), 5307.
Rowlinson, S., Yoshizato, H., Barclay, J., Brooks, A., Behncken, S., Kerr, L., et al. (2008). An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway. Nature cell biology, 10(6), 740-747.
Wan, Y., Zheng, Y., Harris, J., Brown, R., & Waters, M. (2003). Epitope map for a growth hormone receptor agonist monoclonal antibody, MAb 263. Molecular Endocrinology, 17(11), 2240.
Zhu, H. J., & Sizeland, A. M. (1999). A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation. Journal of Biological Chemistry, 274(17), 11773-11781